Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANAKINUMAB vs CANDESARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANAKINUMAB vs CANDESARTAN: Safety Overview

Metric CANAKINUMAB CANDESARTAN
Total FAERS Reports 10,462 9,045
Deaths Reported 518 1,899
Death Rate 5.0% 21.0%
Hospitalizations 2,624 5,063
Average Patient Age 28.8 yrs 61.8 yrs
% Female Patients 55.8% 60.6%
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A